Reversal of mitochondrial abnormalities by CRISPR/Cas9 editing of the mutant HTT allele in vitro in Huntington's Disease patient-derived pluripotent and neural stem cells

被引：0
|
作者：
Lopes, Carla [1 ,2 ]
Schlaeger, Thorsten [2 ,5 ]
de Almeida, Luis Pereira [1 ,6 ]
Daley, George [3 ,4 ,5 ,7 ]
Rego, Cristina [1 ,8 ]
机构：
[1] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal
[2] Univ Coimbra, Inst Interdisciplinary Res, Coimbra, Portugal
[3] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA USA
[4] Dana Farber Canc Inst, Boston, MA 02115 USA
[5] Boston Childrens Hosp, Stem Cell Program, Boston, MA USA
[6] Univ Coimbra, Fac Pharm, Coimbra, Portugal
[7] Harvard Med Sch, Harvard Stem Cell Inst, Boston, MA 02115 USA
[8] Univ Coimbra, Fac Med, Coimbra, Portugal
来源：
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION | 2019年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
S1-O10
引用
收藏
页码：57 / 58
页数：2
相关论文
共 50 条
  • [1] CRISPR/Cas9 Specific Editing of the Mutant HTT Allele
    Monteys, Alex Mas
    Hundley, Ammiel A.
    Lim, Euyn
    Keiser, Megan K.
    Davidson, Beverly L.
    MOLECULAR THERAPY, 2019, 27 (04) : 420 - 420
  • [2] Reversal of Phenotypic Abnormalities by CRISPR/Cas9-Mediated Gene Correction in Huntington Disease Patient-Derived Induced Pluripotent Stem Cells
    Xu, Xiaohong
    Tay, Yilin
    Sim, Bernice
    Yoon, Su-In
    Huang, Yihui
    Ooi, Jolene
    Utami, Kagistia Hana
    Ziaei, Amin
    Ng, Bryan
    Radulescu, Carola
    Low, Donovan
    Ng, Alvin Yu Jin
    Loh, Marie
    Venkatesh, Byrappa
    Ginhoux, Florent
    Augustine, George J.
    Pouladi, Mahmoud A.
    STEM CELL REPORTS, 2017, 8 (03): : 619 - 633
  • [3] Selective deactivation of Huntington disease mutant allele by CRISPR–Cas9 gene editing
    Hemi Malkki
    Nature Reviews Neurology, 2016, 12 (11) : 614 - 615
  • [4] CRISPR/Cas9 repairs patient-derived stem cells
    不详
    LAB ANIMAL, 2016, 45 (03) : 86 - 86
  • [5] CRISPR/Cas9 Editing of the Mutant Huntingtin Allele In Vitro and In Vivo
    Monteys, Alex Mas
    Ebanks, Shauna A.
    Keiser, Megan S.
    Davidson, Beverly L.
    MOLECULAR THERAPY, 2017, 25 (01) : 12 - 23
  • [6] Mitochondrial and Redox Modifications in Huntington Disease Induced Pluripotent Stem Cells Rescued by CRISPR/Cas9 CAGs Targeting
    Lopes, Carla
    Tang, Yang
    Anjo, Sandra, I
    Manadas, Bruno
    Onofre, Isabel
    de Almeida, Luis P.
    Daley, George Q.
    Schlaeger, Thorsten M.
    Carvalho Rego, Ana Cristina
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
  • [7] Genome Editing in Induced Pluripotent Stem Cells using CRISPR/Cas9
    Ben Jehuda, Ronen
    Shemer, Yuval
    Binah, Ofer
    STEM CELL REVIEWS AND REPORTS, 2018, 14 (03) : 323 - 336
  • [8] Genome Editing in Induced Pluripotent Stem Cells using CRISPR/Cas9
    Ronen Ben Jehuda
    Yuval Shemer
    Ofer Binah
    Stem Cell Reviews and Reports, 2018, 14 : 323 - 336
  • [9] F508del editing in patient-derived iPSCs by CRISPR/Cas9
    Kondrateva, E. V.
    Anuchina, A. A.
    Adilgereeva, E. P.
    Amelina, E. L.
    Ustinov, K. D.
    Yasinovsky, M. I.
    Kochergin-Nikitsky, S.
    Zainitdinova, M. I.
    Mozgovoy, I. V.
    Lavrov, A. V.
    Smirnikhina, S. A.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1907 - 1908
  • [10] Universal Correction of Blood Coagulation Factor VIII in Patient-Derived Induced Pluripotent Stem Cells Using CRISPR/Cas9
    Park, Chul-Yong
    Sung, Jin Jea
    Cho, Sung-Rae
    Kim, Jongwan
    Kim, Dong-Wook
    STEM CELL REPORTS, 2019, 12 (06): : 1242 - 1249
12345